These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 16703232)

  • 1. Volatile anesthetics and cardiac function.
    De Hert SG
    Semin Cardiothorac Vasc Anesth; 2006 Mar; 10(1):33-42. PubMed ID: 16703232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The concept of anaesthetic-induced cardioprotection: clinical relevance.
    De Hert SG
    Best Pract Res Clin Anaesthesiol; 2005 Sep; 19(3):445-59. PubMed ID: 16013693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Volatile anesthetics for periprocedural cardiac protection. A review.
    Landoni G; Fochi O; Bignami E; De Simone F; Zangrillo A
    Minerva Cardioangiol; 2008 Aug; 56(4):429-34. PubMed ID: 18614987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac protection by volatile anesthetics. A review.
    Landoni G; Fochi O; Tritapepe L; Guarracino F; Belloni I; Bignami E; Zangrillo A
    Minerva Anestesiol; 2009 May; 75(5):269-73. PubMed ID: 18987572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardioprotection by volatile anesthetics.
    Bienengraeber MW; Weihrauch D; Kersten JR; Pagel PS; Warltier DC
    Vascul Pharmacol; 2005; 42(5-6):243-52. PubMed ID: 15922257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial damage prevented by volatile anesthetics: a multicenter randomized controlled study.
    Guarracino F; Landoni G; Tritapepe L; Pompei F; Leoni A; Aletti G; Scandroglio AM; Maselli D; De Luca M; Marchetti C; Crescenzi G; Zangrillo A
    J Cardiothorac Vasc Anesth; 2006 Aug; 20(4):477-83. PubMed ID: 16884976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardioprotection with volatile anesthetics: clinical relevance.
    De Hert SG
    Curr Opin Anaesthesiol; 2004 Feb; 17(1):57-62. PubMed ID: 17021529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardioprotection with volatile anesthetics in cardiac surgery.
    Lorsomradee S; Cromheecke S; Lorsomradee S; De Hert SG
    Asian Cardiovasc Thorac Ann; 2008 Jun; 16(3):256-64. PubMed ID: 18515682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anaesthesia and myocardial ischaemia/reperfusion injury.
    Frässdorf J; De Hert S; Schlack W
    Br J Anaesth; 2009 Jul; 103(1):89-98. PubMed ID: 19502287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardioprotection by anesthetics].
    Hara T
    Masui; 2006 May; 55(5):552-9. PubMed ID: 16715909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioprotection with volatile anesthetics: mechanisms and clinical implications.
    De Hert SG; Turani F; Mathur S; Stowe DF
    Anesth Analg; 2005 Jun; 100(6):1584-1593. PubMed ID: 15920178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Myocardial preconditioning with volatile anesthetics. General anesthesia as protective intervention?].
    Buchinger H; Grundmann U; Ziegeler S
    Anaesthesist; 2005 Sep; 54(9):861-70. PubMed ID: 16044231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peri-operative anaesthetic myocardial preconditioning and protection - cellular mechanisms and clinical relevance in cardiac anaesthesia.
    Kunst G; Klein AA
    Anaesthesia; 2015 Apr; 70(4):467-82. PubMed ID: 25764404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anesthetic preconditioning: how important is it in today's cardiac anesthesia?
    De Hert SG
    J Cardiothorac Vasc Anesth; 2006 Aug; 20(4):473-6. PubMed ID: 16884975
    [No Abstract]   [Full Text] [Related]  

  • 15. [Organ protective effects of volatile anesthetics and perioperative outcomes].
    Uchino H; Suzuki M; Okita A; Yuhnaiyama Y; Shibuya M; Usui D; Miyashita R; Hatakeyama K
    Masui; 2012 May; 61(5):478-95. PubMed ID: 22702090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardioprotection by volatile anesthetics: new applications for old drugs?
    Pratt PF; Wang C; Weihrauch D; Bienengraeber MW; Kersten JR; Pagel PS; Warltier DC
    Curr Opin Anaesthesiol; 2006 Aug; 19(4):397-403. PubMed ID: 16829721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardioprotection via activation of protein kinase C-delta depends on modulation of the reverse mode of the Na+/Ca2+ exchanger.
    Bouwman RA; Salic K; Padding FG; Eringa EC; van Beek-Harmsen BJ; Matsuda T; Baba A; Musters RJ; Paulus WJ; de Lange JJ; Boer C
    Circulation; 2006 Jul; 114(1 Suppl):I226-32. PubMed ID: 16820577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac preconditioning by volatile anesthetic agents: a defining role for altered mitochondrial bioenergetics.
    Stowe DF; Kevin LG
    Antioxid Redox Signal; 2004 Apr; 6(2):439-48. PubMed ID: 15025946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial protection by anesthetic agents against ischemia-reperfusion injury: an update for anesthesiologists.
    Kato R; Foëx P
    Can J Anaesth; 2002 Oct; 49(8):777-91. PubMed ID: 12374705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Volatile anesthetic-induced cardiac preconditioning.
    Stadnicka A; Marinovic J; Ljubkovic M; Bienengraeber MW; Bosnjak ZJ
    J Anesth; 2007; 21(2):212-9. PubMed ID: 17458651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.